MEK Inhibitor PD-0325901 Overcomes Resistance to CK2 Inhibitor CX-4945 and Exhibits Anti-Tumor Activity in Head and Neck Cancer

International Journal of Biological Sciences - Canada
doi 10.7150/ijbs.10745
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Ivyspring International Publisher

Related search

MEK Inhibitor PD-0325901 Overcomes Resistance to PI3K/mTOR Inhibitor PF-5212384 and Potentiates Antitumor Effects in Human Head and Neck Squamous Cell Carcinoma

Clinical Cancer Research
Cancer ResearchOncology
2015English

CX-4945: The Protein Kinase CK2 Inhibitor and Anti-Cancer Drug Shows Anti-Fungal Activity

Molecular and Cellular Biochemistry
MedicineClinical BiochemistryCell BiologyMolecular Biology
2017English

Synergistic Antitumour Activity of HDAC Inhibitor SAHA and EGFR Inhibitor Gefitinib in Head and Neck Cancer: A Key Role for ΔNp63α

British Journal of Cancer
Cancer ResearchOncology
2019English

TNFα Blockade Overcomes Resistance to Anti-Pd-1 in Experimental Melanoma

Nature Communications
AstronomyGeneticsMolecular BiologyBiochemistryChemistryPhysics
2017English

Simvastatin, an HMG-CoA Reductase Inhibitor, Exhibits Anti-Metastatic and Anti-Tumorigenic Effects in Endometrial Cancer

Gynecologic Oncology
GynecologyOncologyObstetrics
2014English

A Small Molecule Inhibitor of ER-to-cytosol Protein Dislocation Exhibits Anti-Dengue and Anti-Zika Virus Activity

Scientific Reports
Multidisciplinary
2019English

Inhibition of YAP Function Overcomes BRAF Inhibitor Resistance in Melanoma Cancer Stem Cells

Oncotarget
Oncology
2017English

ADAM10 and ADAM17 Cleave PD-L1 to Mediate PD-(L)1 Inhibitor Resistance

OncoImmunology
OncologyAllergyImmunology
2020English

Shipping Out MEK Inhibitor Resistance With SHP2 Inhibitors

Cancer Discovery
Oncology
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy